I agree with this claim because there is evidence showing that obesity rates in America have been going down while the use of weight-loss medications has been going up. Over the past few years, these medications have become more common, and during that same time, the obesity rate has started to decrease. I think this shows that weight-loss medications could be one reason for this change, but there are also other things that can affect obesity rates, like eating habits and physical activity. Overall, the information I found shows a connection between more people using weight-loss medications and obesity rates decreasing in America.
Healthline gives evidence that supports my position by showing how obesity rates and the use of GLP-1 medications have changed. The article reports that the U.S. obesity rate decreased from almost 40% in 2022 to 37% in 2025, which equals about 7.6 million fewer people with obesity. At the same time, the percentage of adults using GLP-1 medications increased from about 6% in 2024 to 12% in 2025. One doctor interviewed for the article said, “It’s good to see this is having an impact.” I think these numbers are important because they show that obesity rates dropped during the same period that the use of these medications greatly increased. While this does not prove that the medications are the only reason for the decrease, it gives strong evidence that they could be playing a role.
According to UCHealth, medications such as Wegovy and Ozempic have helped many people lose a noticeable amount of weight. The article states that the medications are helping people lose “about 12% of body mass, on average.” It also explains that the drugs decrease a person's appetite and make them feel less hungry, which can lead to eating less. UCHealth also says that losing even “5% to 10% of body weight” has been connected to a lower risk of cardiovascular disease in adults. I think this evidence supports my position because it shows that these medications can lead to real changes in a person's weight. If more people are using medications that can help with significant weight loss, it makes sense that they could be contributing to the decrease in obesity rates across the country.
The U.S. News article also discusses the recent decrease in U.S. obesity rates and the rise in GLP-1 weight-loss medication use. Like the other evidence, the report connects the decline in obesity with the large increase in the number of Americans using these medications. This supports my position because the two changes are happening around the same time, which suggests that weight-loss medications could be contributing to the decline. However, it is also important to remember that obesity is affected by many different factors, so medication cannot automatically be considered the only cause. Overall, the evidence from these sources makes me agree that the growing use of weight-loss medications may be one reason obesity rates in America are decreasing.
